OpenAlex
PricingAboutJobs
Log inGet started
Work

Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.

PubMed

Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: Tie-Ming Lü, Shun-Liang Yang, Wei-Zhen Wu, Jian-Ming Tan
Institutions: Fuzhou General Hospital of Nanjing Military Command, Chinese People's Liberation Army
Language: English

Topic: Renal Transplantation Outcomes and Treatments
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Keywords: alemtuzumab, kidney transplantation, induction therapy, antithymocyte globulin, highly sensitized patients, panel reactive antibody, graft survival, acute rejection, infection, immunosuppression, tacrolimus, mycophenolate mofetil, CD52, graft failure, post-transplant mortality, neutropenia, acute myocardial infarction
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W8064881
FWCI: 2.015
Cites:
Cited by: 27
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms